首页> 美国卫生研究院文献>Infection and Immunity >Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.
【2h】

Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.

机译:使用单克隆抗-muramyl二肽抗体可显着增强muramyl二肽对蛋白质抗原和合成的弱免疫原的佐剂活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Priming of mice with complexes of antigen coupled to muramyl dipeptide and monoclonal anti-muramyl dipeptide antibodies enhanced the adjuvant activity of muramyl dipeptide on the humoral response to the antigen. The enhancement did not occur with free (uncoupled) muramyl dipeptide and required the presence of an adjuvant-active hapten within the complex as well as the Fc fragment of the monoclonal antibody. This system proved highly effective in eliciting antibodies to synthetic weak immunogens whereas muramyl dipeptide, on its own, exerts very little or no adjuvant activity. The effect was not due to a general polyclonal activation and was restricted to the antigen coupled to the synthetic adjuvant. Possible pathways involved in this phenomenon are discussed.
机译:用与鼠王氨酰二肽和单克隆抗-村鼠二肽抗体偶联的抗原复合物引发小鼠增强鼠王二酰二肽对抗原的体液应答的佐剂活性。游离的(未偶联的)戊二酰二肽不会发生这种增强,而是需要复合物中的单克隆抗体Fc片段中存在佐剂活性的半抗原。事实证明,该系统在引发针对合成的弱免疫原的抗体方面非常有效,而穆拉米二肽本身仅发挥极少或没有佐剂活性。该作用不是由于普遍的多克隆激活所致,而是限于与合成佐剂偶联的抗原。讨论了此现象可能涉及的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号